Found: 5
Select item for more details and to access through your institution.
SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S28, doi. 10.1093/schbul/sbaa028.063
- By:
- Publication type:
- Article
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [<sup>18</sup>F]BCPP-EF PET study.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01099-1
- By:
- Publication type:
- Article
The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1011, doi. 10.1177/02698811231177287
- By:
- Publication type:
- Article
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-<sup>1</sup>H-MRS Study of Patients With Schizophrenia and Healthy Controls.
- Published in:
- International Journal of Neuropsychopharmacology, 2024, v. 27, n. 3, p. 1, doi. 10.1093/ijnp/pyae011
- By:
- Publication type:
- Article
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14122-0
- By:
- Publication type:
- Article